Flyte Aviation, Inc.
VJET NYSE Surgical & Medical Instruments & Apparatus Financials FY2017βFY2025
What Flyte Aviation, Inc. does
No business description yet.
- Legal name
- Flyte Aviation, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001437749-26-010549
0001716621
Revenue and margins
Flyte Aviation, Inc. had $0.8M of revenue in fiscal 2025, up 95.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$8.3M in fiscal 2025, β1,015.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Flyte Aviation, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Flyte Aviation, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $15.0M | $15.9M | $3.6M | $2.9M | $0.1M |
| Debt incl. finance leases | β | β | β | β | $3.1M |
| Debt / equity | β | β | β | β | 0.4x |
| Current ratio | 3.2x | 2.2x | 1.7x | 1.5x | 0.1x |
| Quick ratio | 3.0x | 2.2x | 1.7x | 1.5x | 0.1x |
| Total assets | $21.0M | $16.8M | $30.7M | $27.8M | $15.9M |
| Total liabilities | $7.4M | $7.6M | $9.5M | $16.0M | $9.2M |
| Shareholders' equity | $13.7M | $9.3M | $21.2M | $11.8M | $7.1M |
| Net debt (β = net cash) | β | β | β | β | $3.0M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 3 / 9 | 2 / 8 | 1 / 8 | 2 / 8 | 3 / 7 | 3 / 7 | 3 / 7 |
| Accruals ratio | β108.6% | β28.9% | β40.3% | β20.0% | 9.4% | β22.7% | β210.0% | β25.2% | β40.7% |
| Altman Z'' | β15.20 | 9.69 | β9.94 | β16.35 | β31.37 | β45.59 | β43.63 | β36.02 | β73.23 |
9 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $5.9M | $6.3M | $7.2M | $4.4M | $0.0M | $0.0M | $0.4M | $0.4M | $0.8M |
| Gross profit | $1.7M | $2.1M | β$1.7M | β$1.9M | β$1.5M | β$0.1M | $0.4M | $0.4M | $0.8M |
| Research and development | $4.5M | $2.8M | $4.5M | $9.0M | $12.3M | $6.4M | $0.5M | $0.3M | $0.9M |
| Operating income | β$17.8M | β$31.2M | β$57.7M | β$35.4M | β$29.3M | β$27.0M | β$78.1M | β$11.2M | β$21.1M |
| Interest expense | $0.0M | $0.0M | $0.3M | $0.1M | β | β | β | β | β |
| Pretax income | β$17.8M | β$30.8M | β$56.9M | β$35.3M | β$27.3M | β$26.9M | β$70.6M | β$13.5M | β$19.5M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $3.1M | β$1.8M |
| Net income | β$17.8M | β$30.8M | β$57.0M | β$36.0M | β$25.1M | β$26.9M | β$70.6M | β$16.6M | β$17.2M |
| Net income to common | β | β | β | β | β | β | β$71.4M | β$21.8M | β$17.2M |
| Diluted EPS | β$2.35 | β$3.34 | β$108.28 | β$21.22 | β$248.22 | β$25.98 | β | β | β |
| Diluted shares | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | β | β | β |
| Cash flow | |||||||||
| Cash from operations | β$5.5M | β$18.5M | β$33.2M | β$28.3M | β$27.6M | β$22.6M | β$20.6M | β$9.3M | β$8.3M |
| Capital expenditure | $0.5M | $0.6M | $0.3M | $0.1M | $0.3M | $0.0M | $0.1M | $0.1M | $0.0M |
| Free cash flow | β$6.1M | β$19.1M | β$33.4M | β$28.4M | β$27.9M | β$22.6M | β$20.7M | β$9.3M | β$8.3M |
| Depreciation and amortization | $0.2M | $0.6M | $1.8M | $2.4M | $1.6M | $0.4M | $2.1M | $2.1M | $2.1M |
| Stock-based compensation | $12.7M | $14.7M | $23.5M | $4.1M | $2.2M | $0.4M | $1.2M | $0.1M | $0.3M |
| Balance sheet | |||||||||
| Cash and short-term investments | $8.2M | $64.3M | $14.6M | $23.9M | $15.0M | $15.9M | $3.6M | $2.9M | $0.1M |
| Total debt | β | $0.9M | $0.6M | β | β | β | β | β | $3.1M |
| Current assets | $10.0M | $69.2M | $36.0M | $27.6M | $17.1M | $16.8M | $4.2M | $3.3M | $0.4M |
| Current liabilities | $2.6M | $6.0M | $6.8M | $7.8M | $5.4M | $7.6M | $2.5M | $2.2M | $3.9M |
| Inventory | $1.2M | $2.1M | $2.8M | $0.9M | $1.0M | $0.0M | $0.0M | $0.0M | $0.1M |
| Property and equipment, net | $1.2M | $4.8M | $5.1M | $2.5M | $1.8M | $0.0M | $0.1M | $0.1M | $0.1M |
| Goodwill | β | β | β | β | β | $0.0M | $0.0M | β | $0.0M |
| Intangible assets | β | β | β | β | β | $0.0M | $26.3M | $24.3M | $15.2M |
| Total assets | $11.3M | $74.0M | $44.1M | $33.4M | $21.0M | $16.8M | $30.7M | $27.8M | $15.9M |
| Total liabilities | $18.9M | $7.3M | $10.9M | $12.3M | $7.4M | $7.6M | $9.5M | $16.0M | $9.2M |
| Shareholders' equity | β$7.6M | $66.7M | $33.2M | $21.1M | $13.7M | $9.3M | $21.2M | $11.8M | $7.1M |
| Margins | |||||||||
| Gross margin | 29.0% | 32.8% | β22.9% | β43.4% | β6,990.9% | β1,050.0% | 93.2% | 90.0% | 92.3% |
| Operating margin | β302.6% | β498.0% | β801.9% | β803.7% | β133,027.3% | β192,578.6% | β17,674.0% | β2,676.9% | β2,581.6% |
| EBITDA margin | β298.8% | β488.0% | β777.6% | β750.0% | β125,913.6% | β189,571.4% | β17,204.5% | β2,174.8% | β2,323.3% |
| Net margin | β302.6% | β492.8% | β791.2% | β818.3% | β113,954.5% | β191,892.9% | β15,966.5% | β3,962.6% | β2,098.0% |
| FCF margin | β103.4% | β305.1% | β464.5% | β644.1% | β126,772.7% | β161,321.4% | β4,682.1% | β2,223.3% | β1,015.0% |
| Returns | |||||||||
| Return on capital | β | β754.9% | β238.5% | β | β | β | β | β | β166.3% |
| Return on capital employed | β205.7% | β45.8% | β154.9% | β137.9% | β187.0% | β291.2% | β276.4% | β44.0% | β176.9% |
| Return on equity | β | β104.3% | β114.1% | β132.8% | β144.0% | β234.3% | β463.5% | β101.0% | β182.7% |
| Return on assets | β157.6% | β72.3% | β96.4% | β93.0% | β92.0% | β141.8% | β296.7% | β56.9% | β78.8% |
| Return on tangible equity | β | β46.2% | β171.8% | β170.4% | β183.4% | β290.1% | β | β | β |
| Growth | |||||||||
| Revenue growth | β | 6.6% | 15.1% | β38.8% | β99.5% | β36.4% | 3,057.1% | β5.0% | 95.0% |
| Share count change | β | 22.3% | β94.3% | 223.0% | β94.1% | 923.8% | β | β | β |
| Financial health | |||||||||
| Debt / equity | β | 0.0x | 0.0x | β | β | β | β | β | 0.4x |
| Interest coverage | β4,440.0x | β2,225.7x | β230.9x | β327.8x | β | β | β | β | β |
| Current ratio | 3.8x | 11.6x | 5.3x | 3.6x | 3.2x | 2.2x | 1.7x | 1.5x | 0.1x |
| Quick ratio | 3.4x | 11.3x | 4.9x | 3.4x | 3.0x | 2.2x | 1.7x | 1.5x | 0.1x |
| Capital allocation | |||||||||
| Capex / revenue | 9.3% | 9.3% | 3.7% | 1.5% | 1,204.5% | 121.4% | 17.2% | 16.0% | 2.1% |
| Stock comp / revenue | 216.5% | 235.4% | 327.0% | 92.7% | 10,168.2% | 3,192.9% | 275.3% | 12.9% | 41.3% |
| Quality scores | |||||||||
| Piotroski F-score | β | 4.0 | 3.0 | 2.0 | 1.0 | 2.0 | 3.0 | 3.0 | 3.0 |
| Altman Z'' | β15.2 | 9.7 | β9.9 | β16.3 | β31.4 | β45.6 | β43.6 | β36.0 | β73.2 |
| Accruals ratio | β108.6% | β28.9% | β40.3% | β20.0% | 9.4% | β22.7% | β210.0% | β25.2% | β40.7% |
Source: SEC EDGAR XBRL filings (CIK 0001716621). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.